Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement Regarding Nomination of Robert F…
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
BIO Released the Following Statement After…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO Statement on Lawsuit Over 340B Rebates
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…
All Press Releases
  • Show All
Search
Results
Event Tags
March 17, 2023
Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…
March 15, 2023
Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…
March 13, 2023
"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…
March 9, 2023
President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy…
March 9, 2023
A broad coalition of national and state agriculture and bioscience organizations have written President Biden to thank the administration for beginning technical consultations with Mexico concerning its action to ban imports of biotech corn. The…
March 6, 2023
The Biotechnology Innovation Organization appreciates that USDA and the Biden Administration are aiming to increase access to modern, innovative seeds. We are reviewing USDA’s report, “More and Better Choices for Farmers: Promoting Fair Competition…
March 6, 2023
The Biotechnology Innovation Organization welcomes today’s announcement by the Office of the U.S. Trade Representative that it is initiating a technical consultation with Mexico over that country’s plan to ban imports of biotech corn. “BIO applauds…
February 28, 2023
Spring 2023 Season Takes a Deep Dive Into Pain Therapies, Artificial Intelligence, FDA’s Accelerated Approvals, and Misinformation   Today, the Biotechnology Innovation Organization (BIO) premieres its new I am BIO podcast season, which tells…
February 21, 2023
The 29-part film takes audiences to the heart of era-defining biotechnology The Biotechnology Innovation Organization (BIO), today launched a 29-part film series, “Nature’s Building Blocks,” spotlighting the role of biotechnology in transforming…
February 15, 2023
HHS yesterday released three payment models for testing by CMS, which HHS believes will lower the cost of prescription drugs. BIO's Chief Policy Officer, John Murphy, made the following statement: "Today, the Department of Health and Human…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.